We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$540M
AUM Growth
-$17.9M
(-3.2%)
Cap. Flow
-$41M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
716
New
62
Increased
152
Reduced
248
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Malaysia ETF
EWM
|
+$10.3M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$9.74M |
| 3 |
IBM
IBM
|
+$8.96M |
| 4 |
iShares MSCI China ETF
MCHI
|
+$8.57M |
| 5 |
Linde
LIN
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$21.8M |
| 2 |
Stellantis
STLA
|
+$20.9M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$11.4M |
| 4 |
Ferrari
RACE
|
+$10.4M |
| 5 |
Deutsche Bank
DB
|
+$9.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.08% |
| 2 | Consumer Discretionary | 12.84% |
| 3 | Technology | 8.88% |
| 4 | Materials | 7.83% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Zebra Technologies
ZBRA
$12.4B
| – | – |
-381
| Closed | -$78.6K |
|
|
CNH
702
CALL
CNH Industrial
CNH
$13.8B
| – | – |
-34
| Closed | -$245 |
|
|
EPZM
703
DELISTED
Epizyme, Inc
EPZM
| – | – |
-6,800
| Closed | -$70.1K |
|
|
ONCE
704
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – |
-20
| Closed | -$1.94K |
|
|
AABA
705
DELISTED
Altaba Inc
AABA
| – | – |
-663
| Closed | -$12.9K |
|
|
CELG
706
DELISTED
Celgene Corp
CELG
| – | – |
-1,013
| Closed | -$101K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2019 Portfolio in Review
As of Q4 2019, Exane Derivatives held 716 positions worth $540M, down 3.2% from $558M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $41M in Q4 2019, closing 35 positions and reducing 248 holdings. Its most notable exit was iShares MSCI Indonesia ETF, an estimated $6.83M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Exane Derivatives opened a new position in IBM worth $9M.
- Exane Derivatives's largest Q4 2019 buy was IBM: 68,905 shares worth $9M.
- Exane Derivatives added most to iShares MSCI Malaysia ETF in Q4 2019, an estimated $10.3M increase.
- Exane Derivatives's biggest Q4 2019 reduction was UBS Group, cutting an estimated $21.8M.
- Exane Derivatives fully exited iShares MSCI Indonesia ETF in Q4 2019, selling an estimated $6.83M.
- Exane Derivatives's ten largest holdings make up 27% of its $540M portfolio in Q4 2019.
- Exane Derivatives opened 62 new positions and closed 35 in Q4 2019.
- Exane Derivatives's portfolio value fell 3.2% quarter-over-quarter to $540M.
Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.